ASX shares 22/02/24 PAA DUG IPG ACF

ASX shares 22/02/24 PAA DUG IPG ACF

Stocks pick today are PAA, DUG, IPG, ACF.

1. Top gainers

#SectorCODEASX SharePriceCap (M)PE
1Health TechnologyPAAPHARMAUST LIMITED0.3095
2Technology ServicesDUGDUG TECHNOLOGY LTD2.6331242.69

Screenshot

Real time chart, change Code to update

PAA PharmAust Ltd

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.

PAA financials

PAA Price sensitive announcement

#DATEANNOUNCEMENTNO. OF PAGES
122nd Feb 2024PharmAust Forms World-Class Scientific Advisory Board3
216th Feb 2024FDA Outlines Pathway to Accelerated Approval for MPL in MND2
314th Feb 2024Extension Study Begins, Analysis Suggests Survival Benefit3
431st Jan 2024Appendix 4C & Quarterly Update11
530th Jan 2024Ethics Committee Approval for Open-Label MND Extension Study2
629th Jan 2024FDA Provides Clear Feedback for ODD Approval2
716th Jan 2024PharmAust Partners with Berry Consultants for MND Phase 2/32
82nd Jan 2024FDA Grants PharmAust Pre-IND Meeting2
922nd Dec 2023FightMND Invites PharmAust to Apply for Phase 2/3 Funding2
1020th Dec 2023PharmAust Receives R&D Tax Incentive Refund2

DUG Technology Ltd

DUG Technology Ltd is a technology company providing high performance computing as a service (HPCaaS), scientific data analysis services, and software solutions for the technology and resource sectors. Also, the company offers data management, multi-tiered support for optimising third-party algorithms, and integrated scientific software and services. The company has Three reportable segments which includes HPCaaS, Services, and Software segments and the company generates majority of its revenue from services segment.

DUG financials

DUG Price sensitive announcement

#DATEANNOUNCEMENTNO. OF PAGES
12nd Feb 2024Update regarding new compute2
21st Dec 2023S&P DJI Announces December 2023 Quarterly Rebalance2
330th Oct 2023Q1 FY24 Business Update3
429th Aug 2023Asset Financing Arrangements Executed2
528th Aug 2023FY2023 Investor Presentation34
628th Aug 2023FY2023 Results Release3
728th Aug 2023Preliminary Final Report1
815th Aug 2023DUG receives A$7.1m from loan funded share plan repayment1
918th Jul 2023DUG secures A$5 million in government funding for Geraldton3
1018th Jul 2023Trading Halt2

2. All high time shares

High#SectorCODEASX SharePriceCap (M)PE
ATH1UtilitiesIPGIPD GROUP LTD5.3346028.9
52W2FinanceACFACROW LIMITED1.18033012.94

IPG financials

IPG Price sensitive announcement

#DATEANNOUNCEMENTNO. OF PAGES
131st Jan 2024Acquisition Completion of CMI Operations1
225th Jan 2024Acquisition Update of CMI Operations2
325th Jan 2024IPD Group enters into Facility Agreement1
419th Dec 2023Completion of Retail Entitlement Offer2
55th Dec 2023Retail Entitlement Offer opens and Retail Offer Booklet113
630th Nov 2023Completion of Placement and Institutional Entitlement Offer5
728th Nov 2023CEO Presentation19
828th Nov 2023Investor Presentation55
928th Nov 2023Acquisition of CMI Operations and Equity Raising8
1028th Nov 2023Trading Halt2

ACF financials

ACF Price sensitive announcement

#DATEANNOUNCEMENTNO. OF PAGES
120th Feb 2024FY24 Half Year Results Presentation50
220th Feb 2024Acrow reports another period of Record Financial Results5
320th Feb 2024Half Yearly Report and Accounts24
46th Nov 2023Acquisition of MI Scaffold and Equity Raising27
56th Nov 2023Acrow bolsters capability with acquisition of MI Scaffold6
63rd Nov 2023Trading Halt2
73rd Nov 2023Pause in Trading1
814th Aug 2023FY23 Full Year Results Presentation49
914th Aug 2023FY23 Preliminary Final Results5
1014th Aug 2023Appendix 4E – Preliminary Final Report22

Conclusion

Pick up by financials: None

Pick up by news:

Post Comment